[Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults].
Höffken
G
G
Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. gert.hoeffken@uniklinikum-dresden.de
Lorenz
J
J
Kern
W
W
Welte
T
T
Bauer
T
T
Dalhoff
K
K
Dietrich
E
E
Ewig
S
S
Gastmeier
P
P
Grabein
B
B
Halle
E
E
Kolditz
M
M
Marre
R
R
Sitter
H
H
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D003430:Cross-Sectional Studies; D004334:Drug Administration Schedule; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006760:Hospitalization; D006801:Humans; D007362:Intensive Care Units; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D011550:Pseudomonas aeruginosa; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D012307:Risk Factors; D015996:Survival Rate
D000900:Anti-Bacterial Agents